US Corporate Board Director Changes SEC Filings — April 16, 2026

16-04-2026

Eton Pharmaceuticals, Inc. (Nasdaq: ETON) announced Judith M. Matthews as Executive Vice President, Accounting and Finance, effective immediately, with her assuming the CFO role on June 1, 2026, succeeding James Gruber, who will step down May 31, 2026, and transition to a six-month consulting agreement. CEO Sean Brynjelsen highlighted Gruber's leadership during rapid growth and Matthews' extensive pharma finance experience from Iterum Therapeutics and Durata Therapeutics. The company operates 10 commercial rare disease products and has 4 late-stage development candidates.

• ·Judith M. Matthews previously served as CFO of Iterum Therapeutics plc (2015-2026) and VP Finance at Durata Therapeutics until its acquisition by Actavis plc.
• ·Matthews holds a B.A. in Accounting from University of Illinois at Urbana-Champaign and Master of Management in Finance and Marketing from Kellogg School of Management at Northwestern University.
• ·Investor contact: Lisa M. Wilson, In-Site Communications, Inc. (212-452-2793, lwilson@insitecony.com)

16-04-2026

First Business Financial Services, Inc. appointed David R. Seiler, current President and COO since January 2023, as President, Chief Executive Officer, and Class III Director effective May 3, 2026, succeeding retiring CEO Corey A. Chambas whose retirement was announced in May 2025. The appointment coincides with a new five-year employment agreement providing a minimum annual base salary of $600,000, eligibility for incentive plans, and a $215,000 restricted stock unit grant vesting over five years. The agreement includes standard severance provisions, such as two times base salary upon termination without cause, and customary restrictive covenants.

• ·Employment agreement effective May 3, 2026, with initial 5-year term and automatic 1-year renewals unless 60 days' notice
• ·RSU vesting schedule: 15% on each of first four anniversaries, 40% on fifth anniversary, subject to continued employment
• ·Severance for termination without Cause or for Good Reason: 2x then-current base salary over 24 months, prorated incentive, 18 months health coverage
• ·Mr. Seiler has over 30 years of financial services experience; prior Managing Director at BMO Harris Bank
• ·Appointment to Board as Class III Director until 2028 Annual Meeting

16-04-2026

On April 13, 2026, the Compensation Committee of Aware, Inc. approved the Executive Bonus Plan for 2026, establishing target bonuses for key executives tied to Revenue (50% weight) and Adjusted EBITDA (50% weight) performance goals. Ajay Amlani (CEO and President) has a target of $200,000, Brian Krause (Chief Revenue Officer) and Lona Therrien (Chief Marketing Officer) each $120,000, and David Traverse (Chief Financial Officer) $100,000. Bonuses are payable starting at 25% for meeting thresholds, 100% at targets, with up to 100% additional for enhanced targets, but no bonuses if Adjusted EBITDA threshold is not met.

• ·Adjusted EBITDA defined as net income per GAAP excluding interest, taxes, depreciation, amortization, goodwill/intangible impairments, stock-based compensation, and bonuses under this Plan or 2026 company-wide bonus plan.
• ·No bonuses payable for a Performance Goal if below Threshold; linear interpolation between Threshold (25% payout) and Target (100% payout); up to additional 100% for enhanced target via linear interpolation, capped there.
• ·Overall Adjusted EBITDA must meet or exceed defined threshold for any bonuses to be payable under the Plan.

16-04-2026

Aixin Life International, Inc. (AIXN) appointed Qiyu Jiang, age 40, as a director and Secretary of the Company and its subsidiaries, effective April 15, 2026. Mr. Jiang brings experience from his prior role as Executive Director at Jiujiang Gongqingcheng Dishi Investment Management Co., Ltd. (2017-2022) and current independent options trading activities. No family relationships or special arrangements were noted regarding the appointment.

• ·Mr. Jiang graduated from INSEEC Paris School of Business in March 2015.
• ·Mr. Jiang became a Chartered Financial Analyst Level I Candidate in June 2024 and received a Legal Professional Qualification Certificate in August 2021.
• ·Mr. Jiang is fluent in Mandarin, French, and English.
• ·Company address: Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District, Chengdu City, Sichuan Province, China 610021.
• ·Trading symbol: AIXN on OTCQX.

16-04-2026

On April 15, 2026, American Resources Corporation held its Annual Meeting of Stockholders, electing five directors—Mark C. Jensen (98.14% for), Mark J. LaVerghetta (77.36%), Courtenay O. Taplin (80.62%), D. Joshua Hawes (79.86%), and Dr. Gerardine G. Botte (81.77%)—and ratifying GreenGrowth CPAs as independent auditors (61,770,593 votes for). Effective the same day, Mark LaVerghetta was appointed to the Board and Nominating Committee, while Thomas Sauve stepped down as director but continues in a non-officer business strategy role with no disagreements reported.

• ·Thomas Sauve's resignation as director effective April 15, 2026, not due to any disagreement with Company operations, policies, or practices.
• ·Mark LaVerghetta, age 52, holds Bachelor of Arts in Economics from University of Virginia; no related-party transactions under Item 404(a).
• ·Directors elected to serve until 2027 Annual Meeting.

16-04-2026

On April 15, 2026, the Board of AES Ohio appointed Gustavo Garavaglia as Chief Executive Officer effective immediately, replacing Kenneth J. Zagzebski who transitions to Executive Chairman; Thomas A. Raga continues as President. The Board also elected Sherry Kohan as Vice President, Chief Financial Officer, and Controller (principal accounting officer) effective May 7, 2026, with Garavaglia serving in the interim CFO role. Officers participate in general AES compensation plans exceeding $120,000 annually, with no other reportable transactions under Item 404(a).

• ·Garavaglia rejoined AES Ohio as VP and CFO in April 2024; previously CFO at Vale Base Metals (2022-2024) and at AES affiliates.
• ·Kohan has been SVP and Chief Accounting Officer at AES since November 2022; previously interim CFO at AES Ohio and affiliates (Jan-Apr 2024).

16-04-2026

The AES Corporation announced the transition of Sherry Kohan from Senior Vice President and Chief Accounting Officer to Chief Financial Officer of AES U.S. Utilities, effective May 7, 2026, with Aubrey Jarred appointed as Vice President and Controller and principal accounting officer on the same date. Bernerd Da Santos stepped down as Executive Vice President and President of US & Renewables on April 16, 2026, transitioning to Chairman of the AES Clean Energy Board and Senior Strategic Advisor to the President. No performance disruptions or financial impacts were disclosed.

• ·Aubrey Jarred's prior roles: Managing Director, Technical Accounting Services at AES since 2022; leadership at LKQ Corporation (2013-2022); KPMG LLP (early career).
• ·No family relationships, arrangements, or material interests for Aubrey Jarred per Regulation S-K Items 401(d) and 404(a).
• ·Jarred eligible for standard AES executive benefits and indemnification agreement.

16-04-2026

On April 15, 2026, IPALCO Enterprises, Inc. and AES Indiana appointed Gustavo Garavaglia as President and CEO of IPALCO and CEO of AES Indiana, replacing Kenneth J. Zagzebski, who transitioned to Executive Chairman. Sherry Kohan was elected as Vice President, CFO, Controller, and principal accounting officer for both entities, effective May 7, 2026, with Garavaglia serving in the interim CFO role. No specific compensation details beyond general AES plans exceeding $120,000 annually were disclosed, and no other material transactions were reported.

• ·Gustavo Garavaglia, 40, rejoined AES Indiana in April 2024; previously CFO of Vale Base Metals (2022-2024) and AES (2018-2022).
• ·Sherry Kohan, 57, Senior VP and Chief Accounting Officer at AES since Nov 2022; interim CFO roles in 2024.
• ·Garavaglia holds degrees from University of Campinas and FGV Brazil, CFA Charterholder.
• ·Kohan is CPA with B.S. in Accounting from University of Maryland.

16-04-2026

On April 15, 2026, Xilio Therapeutics, Inc. elected Cheryl R. Blanchard, Ph.D. as a Class III director with a term expiring at the 2027 annual meeting, appointed her as chair of the Compensation Committee and member of the Audit Committee, succeeding Christina Rossi who resigned effective the same date without any disagreement with the company. Dr. Blanchard will receive standard non-employee director compensation including an annual cash retainer of $40,000, $12,000 as Compensation Committee chair, $7,500 as Audit Committee member, an initial stock option for 10,000 shares, and eligibility for annual options of 5,000 shares. No financial results or performance metrics are disclosed in this filing.

• ·Stock options have exercise price equal to Nasdaq closing price on grant date and expire in ten years.
• ·Initial option vests one-third annually over three years; annual options vest on first anniversary or prior to next annual meeting.
• ·Exhibits include Amended and Restated Non-Employee Director Compensation Policy (10.1).

16-04-2026

On April 9, 2026, Walter Geldenhuys resigned as Chief Executive Officer, Interim Chief Financial Officer, and sole member of the Board of Directors of Rivulet Entertainment, Inc., with no disagreements cited. Michael Witherill was appointed to the Board of Directors on the same date. The Company lacks separate audit, nominating, or compensation committees, and Mr. Witherill previously provided film production services for $391,000, with $86,000 outstanding.

• ·Services provided by Mr. Witherill cover the two years ended June 30, 2025.
• ·Company has no separate audit, nominating, or compensation committees.

16-04-2026

AMERISAFE, Inc. (Nasdaq: AMSF) announced the appointment of Guillermo A. Ramos as Executive Vice President and Chief Financial Officer, effective May 7, 2026. Ramos, previously Head of Finance Strategy at Hiscox US and with prior roles at Equifax, was praised by CEO Janelle Frost for his financial expertise, strategic skills, and cultural fit to support the company's growth.

• ·AMERISAFE focuses on small to mid-sized employers in hazardous industries including construction, trucking, logging and lumber, agriculture, services, manufacturing, and maritime.

16-04-2026

AstroNova, Inc. entered into Stock-Settled Performance Award Amendment Agreements on April 10, 2026, with four key executives: President and CEO Jorik Ittmann, VP and CFO Thomas DeByle, SVP and GM-Aerospace Thomas Carll, and CTO and VP-Technical & Strategic Alliances Michael Natalizia. The amendments allow the Human Capital and Compensation Committee to settle the prior Stock Settled Performance Awards in cash rather than shares, at its discretion. No other terms of the awards were modified.

16-04-2026

On April 10, 2026, Sensei Biotherapeutics, Inc. announced conditional resignations from the Board by directors Christopher W. Gerry, Thomas Ricks, and Kristian Humer, effective two business days after the June 10, 2026 Annual Meeting if stockholders approve the Conversion Proposal (issuance of shares >20% of outstanding common stock upon Series B Preferred conversion, triggering change of control) and Charter Amendment Proposal (increasing authorized common shares from 12,500,000 to 300,000,000). The Board conditionally appointed Stephen M. Hahn, Saira Ramasastry, and Karen Vousden as new directors, anticipates naming Anand Parikh as CEO (replacing Gerry as principal executive officer) and Brian Stephenson as CFO (replacing Josiah Craver as principal financial officer), with no disagreements cited for resignations. The Board also adopted the Severance and Change in Control Plan for executives like Gerry, Craver, and Parikh, providing standard severance of 6-12 months base salary and enhanced CIC benefits of 12-18 months plus bonuses.

• ·Resignations not due to any disagreement on operations, policies, or practices.
• ·Expected committee composition post-Effective Time: Audit (Donenberg Chair, Ramasastry, Holmen); Compensation (Holmen Chair, Ramasastry, Vousden); Nominating/Governance (Vousden Chair, Donenberg, Hahn).
• ·Severance benefits conditioned on release of claims effective within 60 days; subject to clawback policy.
• ·Preliminary Proxy Statement filed April 16, 2026, for proposal details.

16-04-2026

Raj Judge, EVP of Corporate Strategy and Board member of Zscaler, Inc., resigned from both his officer and director positions effective April 15, 2026, with his full departure as EVP effective July 31, 2026. The resignation from the Board is not due to any disagreements with the Company on operations, policies, or practices. In connection with his departure, Mr. Judge expects to receive severance benefits under the Company’s Change of Control and Severance Policy.

• ·Form 8-K filed on April 16, 2026, reporting event of April 15, 2026
• ·Severance Policy previously filed as exhibit to 8-K on December 2, 2024

16-04-2026

Aktis Oncology, Inc. (NASDAQ:AKTS) appointed Glenn Gormley, MD, PhD, as an independent director and co-chair of its newly established Science and Technology Committee, bringing over three decades of biopharmaceutical leadership from roles at Daiichi Sankyo, AstraZeneca, Novartis, and Merck. Concurrently, board members Helen Kim and Oleg Nodelman, early Series A investors, will step down effective May 20, 2026, after five years of service. The appointment supports Aktis' progress in its miniprotein radioconjugate platform and pipeline programs including AKY-1189 and AKY-2519.

• ·Dr. Gormley led the development of Daiichi Sankyo’s ADC platform and served as Chief Medical Officer at AstraZeneca and Global Head of Clinical Development at Novartis.
• ·Aktis has a strategic collaboration with Eli Lilly and Company for novel radioconjugates outside its proprietary pipeline.
• ·Helen Kim and Oleg Nodelman provided five years of service from Series A stage through public transition.

16-04-2026

On April 15, 2026, Kenneth Fearn (Audit Committee member) and Christopher Krug (Compensation Committee member) resigned from the Board of Directors of Greenidge Generation Holdings Inc., effective immediately, with no disagreements on company matters. The Board approved accelerated full vesting of their outstanding RSUs granted in 2025. The company thanked them for their service.

• ·RSUs granted on April 17, 2025 and November 9, 2025
• ·Registrant is an emerging growth company

16-04-2026

Myomo, Inc. (NYSE American: MYO) appointed William 'Will' Febbo as a director effective April 14, 2026, increasing its Board to six members until the 2028 annual meeting. Febbo brings over 30 years of experience in healthcare and technology, including growing OptimizeRx Corporation revenue from $5 million to $92 million with a 41% five-year CAGR during his CEO tenure from 2015 to 2024. CEO Paul R. Gudonis highlighted Febbo's expertise in scaling direct-to-patient solutions and capital markets as key to Myomo's 2026 strategy.

• ·Febbo currently CEO and Director of Performance Health Systems (joined February 2026)
• ·Myomo headquartered in Burlington, Massachusetts
• ·MyoPro uses patient's EMG signals for non-invasive arm function restoration

16-04-2026

Applied Digital Corporation granted fully vested Management Incentive Plan Units (MIP Units) to four executive officers—Wes Cummins, Jason Zhang, Saidal Mohmand, and Laura Laltrello—on April 9, 2026, in connection with the proposed Contribution and Exchange Agreement involving Ekso Bionics Holdings, Inc. These awards, issued under a new APLD ChronoScale Management LLC Equity Incentive Plan, represent approximately 5.25% of the EKSO common stock shares to be issued to Holdco. The MIP Units are designed to track appreciation in EKSO equity held by the Company through Holdco, incentivizing participation in Holdco Group success.

• ·MIP Units fully vested upon grant.
• ·Awards track appreciation in EKSO equity held by Company through Holdco.
• ·Event date: April 10, 2026 (earliest reported); Filing date: April 16, 2026.

16-04-2026

TON Strategy Company (TONX) appointed Kevin Wilson as Chief Executive Officer effective May 4, 2026, following Board approval on April 16, 2026. Wilson, a fintech executive with over 20 years of experience including roles at Integral Development Corp., ROAM Capital, and Citi, entered an employment agreement with a base salary of $950,000, $250,000 signing bonus, 100% target annual bonus (guaranteed at target for 2026 prorated and 1/6th for 2027), and equity awards of at least 2% of fully diluted shares post-June 2026 Annual Meeting. The agreement includes severance of 1x base plus prorated bonus upon qualifying termination, at-will employment, and Board nomination.

• ·No arrangements or understandings with other persons for appointment; no family relationships or disclosable transactions under Item 404(a).
• ·Guaranteed bonus: prorated target for 2026; no less than 1/6th target for 2027.
• ·Equity grants per Company’s equity grant policy after June 2026 Annual Meeting.
• ·Company to nominate Wilson for Board election while employed.

16-04-2026

On April 14, 2026, Michael L. Swenson, a member of the Board of Directors of Citizens Community Bancorp, Inc. (CZWI) since May 2011, provided notice that he will continue serving until the 2026 annual meeting of stockholders on June 16, 2026, but does not plan to stand for re-election. Mr. Swenson's decision is not due to any disagreement with the Company. The filing was signed by James S. Broucek, Chief Financial Officer, on April 16, 2026.

• ·Company incorporated in Maryland; NASDAQ: CZWI; Principal offices in Eau Claire, WI.

16-04-2026

At the April 16, 2026 Annual Meeting of Shareholders, Farmers National Banc Corp. shareholders elected four Class I directors (Gregory C. Bestic, Kevin J. Helmick, Neil J. Kaback, Terry A. Moore) for three-year terms, approved the 2026 Equity Incentive Plan reserving 1,000,000 common shares, ratified Crowe LLP as independent auditors for the fiscal year ending December 31, 2026 with overwhelming support (99.5% of votes cast), and passed an advisory vote on 2025 named executive officer compensation with 85.28% in favor. Voting represented 78.58% of the 37,738,759 outstanding common shares, including 6,608,999 broker non-votes. While all proposals achieved majority approval, significant votes were withheld from some director nominees (e.g., 3,634,533 for Terry A. Moore) and opposition noted on the equity plan (3,005,759 against).

• ·Proxy statement filed March 16, 2026 detailing Proposal Four on the Plan.
• ·Record date for meeting: February 25, 2026.
• ·Proposal 1 director votes: Bestic (20,337,411 For / 2,707,591 Withheld); Helmick (20,667,467 For / 2,377,535 Withheld); Kaback (20,764,097 For / 2,280,905 Withheld); Moore (19,410,468 For / 3,634,533 Withheld).
• ·Proposal 2 exec comp: 19,651,675 For / 2,837,970 Against / 555,356 Abstain.
• ·Proposal 3 auditor: 29,426,210 For / 119,658 Against / 106,458 Abstain.
• ·Proposal 4 Plan: 19,530,286 For / 3,005,759 Against / 508,956 Abstain.

16-04-2026

Corbus Pharmaceuticals Holdings, Inc. entered into sixth amended and restated employment agreement with CEO Yuval Cohen, Ph.D., effective April 15, 2026, for two years with annual base salary of $673,625 and bonus target up to 60% of base salary, and seventh amended agreement with CFO Sean Moran with base salary of $501,273 and bonus up to 40%. Both include equity award eligibility, non-compete (6 months post-termination), non-solicitation (12 months), and severance provisions including 12 months base salary (or more in change of control scenarios), COBRA reimbursement, and accelerated vesting. No prior salary comparisons or performance metrics provided.

• ·Agreements expire April 15, 2028.
• ·CEO severance: 12 months base salary (24 months in Change in Control Period), COBRA for 12/24 months, pro-rated bonus, accelerated equity vesting in CIC.
• ·CFO severance: 12 months base salary (18 months in Change in Control Period), COBRA for 12/18 months, pro-rated bonus (target in CIC), accelerated equity vesting in CIC.
• ·Severance subject to release execution, non-compete compliance, and potential reduction under IRC Section 4999.

16-04-2026

Lincoln National Corporation announced the planned retirement of Brian Kroll, Executive Vice President, Head of Retail Life and Annuity Solutions, and named executive officer, effective June 1, 2026. This is part of a planned succession for the Retail Life and Annuities businesses. No successor was named in the filing.

• ·Filing date: April 16, 2026
• ·Company's 2026 proxy statement filed with SEC on April 16, 2026
• ·Common Stock (LNC) and Depositary Shares (LNC PRD) registered on New York Stock Exchange

16-04-2026

IP Strategy Holdings, Inc. (Nasdaq: IPST) announced the appointment of Brian C. Jun to its Board of Directors, effective April 16, 2026, to bolster expertise in cryptocurrency, tax, and AI. Mr. Jun, currently CFO of Gurufin Inc., has over 15 years of experience advising Web3 projects including Andreessen Horowitz portfolio companies and previously led blockchain taxation at Deloitte for clients like Uniswap, Aave, Solana, and OpenSea. The appointment supports IPST's $IP token treasury strategy and exposure to the $80 trillion programmable IP economy via the Story blockchain, backed by $136 million in funding.

• ·Story blockchain mainnet launched in February 2025
• ·Mr. Jun previously advised IP Strategy on digital asset tax matters as a contractor
• ·Mr. Jun holds J.D. and LL.M. in Taxation from Loyola Law School, Los Angeles, and B.A. from University of California, Berkeley; admitted to State Bar of California

16-04-2026

On April 13, 2026, GitLab Inc. Director Merline Saintil notified the Board of her decision to step down from the Board and the Compensation and Leadership Development Committee, effective April 15, 2026, with no disagreement on operations, policies, or practices. The Board appointed current Lead Independent Director Godfrey Sullivan to fill the committee vacancy and reduced the Board size from nine to eight members, also effective April 15, 2026.

• ·Filing signed by Robin Schulman on April 16, 2026
• ·Class A Common Stock trades as GTLB on Nasdaq

16-04-2026

On April 10, 2026, the Compensation Committee of Quanta Services, Inc. approved performance stock units (PSUs) to named executive officers Earl C. Austin, Jr. (17,759 target), Jayshree S. Desai (8,879), Karl W. Studer (12,431), and Gerald A. Ducey, Jr. (7,103), as strategic incentives aligned with the company's five-year business strategy. The PSUs may be earned up to 300% of target based on adjusted EPS CAGR and up to an additional 200% TSR multiplier by December 31, 2030, for a maximum of 600%, vesting after the performance period subject to continued service. These awards recognize leadership contributions and aim to drive long-term stockholder value creation.

• ·PSUs range from 0% to 600% of target based on performance goals, with vesting after Dec 31, 2030 subject to continued service.
• ·Accelerated vesting possible upon qualifying terminations or change in control.
• ·Awards filed under Exhibit 10.1: Form of PSU Award Agreement.

16-04-2026

WesBanco, Inc. held its Annual Meeting of Shareholders on April 15, 2026, where six directors were elected to the Board with majority support (for votes ranging 65.4M to 69.9M shares, withheld 1.7M to 6.2M). Shareholders approved the 2026 Equity Incentive Plan (68.0M for vs 2.8M against) and overwhelmingly ratified Deloitte & Touche LLP as auditors (81.7M for vs 1.1M against), but the advisory vote on 2025 named executive officer compensation passed narrowly with significant opposition (45.7M for vs 25.0M against).

• ·Annual Meeting held April 15, 2026; definitive proxy filed March 13, 2026
• ·Directors elected for terms expiring 2029 (five directors) or 2027 (Joseph R. Robinson)
• ·All proposals approved despite broker non-votes of 11,506,105 shares on most items

16-04-2026

On April 16, 2026, Terrestrial Energy Inc. entered into new employment agreements with three executive officers—Brian Thrasher (CFO, $350,000 base salary, 43% bonus target), William Smith (COO, $330,000 base salary, 20% bonus target), and David LeBlanc (CTO and Board member, $250,000 base salary, 20% bonus target)—replacing prior agreements. These agreements provide eligibility for equity awards under the 2025 Equity Incentive Plan and severance benefits including 6 months of base salary continuation, pro-rata bonus, accelerated vesting of certain equity, and benefits continuation upon termination without cause. No financial performance metrics or changes in roles were disclosed.

• ·Severance for all executives includes 6-month base salary continuation, pro-rata annual bonus, and accelerated vesting of time-based equity scheduled to vest within 6 months of termination.
• ·Thrasher agreement includes COBRA premium reimbursement for up to 6 months; Smith and LeBlanc agreements provide Canadian benefits continuation for up to 6 months.
• ·All agreements contain 6-month non-competition and non-solicitation covenants post-termination.

16-04-2026

NETGEAR, Inc. disclosed that Board member Bradley L. Maiorino will not stand for re-election at the 2026 Annual Meeting due to increased demands from his new full-time executive role, with no disagreements on company operations, policies, or practices. He will continue serving as director, Chair of the Cybersecurity Committee, and member of the Audit Committee until the Annual Meeting, after which the Board will appoint replacements. The company expressed thanks for his 8 years of service.

• ·Date of earliest event reported: April 12, 2026
• ·Filing date: April 16, 2026
• ·Annual Meeting: 2026

16-04-2026

Axe Compute Inc. announced the resignation of CFO Josh Blacher, effective May 18, 2026, not due to any disagreement with the company. The Board appointed Jeremy Yaukey-Witter, the current Controller, as co-CFO alongside Blacher until May 18, 2026, and sole CFO thereafter, with an annual base salary of $280,000 and 225,000 stock options granted at $3.51 per share. This represents a smooth internal transition with no reported conflicts or material interests.

• ·Jeremy Yaukey-Witter joined Axe Compute Inc. in April 2023; previously at KPMG LLP.
• ·Annual cash bonus target: 0% to 40% of base salary, or higher at Compensation Committee discretion.
• ·Stock options vesting: one-third (rounded down) on one-year anniversary of April 16, 2026; remaining in 1/36th monthly installments thereafter.
• ·No arrangements, family relationships, or material interests under Item 404(a) for Yaukey-Witter.

16-04-2026

On April 10-13, 2026, Toppoint Holdings Inc. announced the resignations of directors Florence Ng and Tan Ying Lo, and interim CFO Kah Loong Randy Yeo, all citing personal reasons with no disagreements on company operations, policies, or practices. The Board appointed Tianheng Li as a new director, Audit Committee member, and chair of Compensation and Nominating Committees (with nil annual cash compensation), and Pei Zhang as new CFO and director (with $50,000 annual base salary and eligibility for bonuses/equity). No family relationships, arrangements, or related party transactions were disclosed for the appointees.

• ·Tianheng Li has over 15 years of experience in communications, consulting, digital commerce, and international affairs.
• ·Pei Zhang has experience in finance, fund operations, accounting, and reporting from roles at GDA Asset Management, BlackRock, and others.
• ·Exhibits include Independent Director Agreement (10.1), Employment Agreement (10.2), and Indemnification Agreement (10.3).

16-04-2026

LifeVantage Corporation (Nasdaq: LFVN) announced the appointment of Terrence Moorehead as President, Chief Executive Officer, and Board member effective August 5, 2026, citing his 25+ years of experience including leading Nature’s Sunshine Products through a transformation that increased revenue 45% and EBITDA 190%. Current President and CEO Steve Fife will retire effective April 30, 2026, with Board member Michael Beindorff appointed as Interim CEO supported by Chief Sales Officer Kristen Cunningham and Chief Financial Officer Carl Aure to ensure a smooth transition. The Board praised Fife's nine-year contributions to modernizing the business, expanding products, and strengthening finances.

• ·Moorehead previously served as CEO of Carlisle Etcetera LLC (2015-2018), Dana Beauty, Inc. (2013-2015), and various roles at Avon Products, Inc. (1991-2013).
• ·LifeVantage founded in 2003, headquartered in Lehi, Utah.

16-04-2026

MiMedx Group, Inc. (MDXG) announced a restructuring and cost reduction initiative, eliminating the Chief Operating Officer position held by Ricci Whitlow and expecting annualized operating expense savings of approximately $40 million, offset by a one-time restructuring charge of about $4 million in Q2 2026. While the Surgical business continues to flourish and warrants investment, the Wound Care business is recovering slowly from the January 1 Medicare reimbursement reduction, prompting these cost adjustments. The company plans to discuss Q1 2026 results and reorganization impacts on its late April conference call.

• ·Surgical business continues to flourish and warrants additional investments.
• ·Wound Care business and broader market recovering at a very slow rate from January 1st Medicare reimbursement reduction.
• ·Q1 2026 operating and financial results commentary planned for late April quarterly conference call.

16-04-2026

Prime Medicine, Inc. appointed Svetlana Makhni, age 42, as Chief Financial Officer and principal financial officer effective April 16, 2026, following Board approval on April 7, 2026. Ms. Makhni brings over 20 years of experience, including prior CFO roles at Marengo Therapeutics (June 2022-April 2026) and Escient Pharmaceuticals (May 2021-June 2022), as well as investment banking at BMO Capital Markets, Goldman Sachs, and others. Allan Reine, M.D. will step down as principal financial officer effective April 16, 2026, but continue as Chief Executive Officer and principal executive officer.

• ·Employment agreement includes severance of 9 months base salary plus 0.75x target bonus (or 12 months base plus 1.0x target bonus post-change in control), COBRA premium support for up to 12 months, and accelerated vesting of time-based equity post-CIC.
• ·800,000-share option vests 25% after one year then monthly over 36 months; 100,000-share option vests on milestones.
• ·Ms. Makhni holds M.B.A. from Harvard Business School and B.S. from Wharton School.
• ·No family relationships or material transactions involving Ms. Makhni.

16-04-2026

Hycroft Mining Holding Corporation appointed Eric Colby as Executive Vice President, Corporate Development, an executive with nearly two decades of mining experience, including 15 years at Newmont Corporation and over $20 billion in executed transactions. CEO Diane Garrett emphasized Colby's operational expertise and credibility to advance the Hycroft Mine toward production amid ongoing exploration efforts. No financial metrics or performance declines were reported in the announcement.

• ·Hycroft Mine is located in northern Nevada, a Tier-1 mining jurisdiction.
• ·Company focused on transitioning from oxide heap leach to milling operations for sulfide mineralization.

16-04-2026

GBT Technologies, Inc. (OTC PINK: GTCH) appointed Minh Collins as President of its wholly owned subsidiary Cube X Media Corporation, effective April 10, 2026. Collins, a film and commercial producer with over 20 years of experience and directing credits including Qualifying (2021), Clown Fear (2020), Rocking the Couch (2019), and Hit List, will lead content strategy for digital advertising, vertical video, and cinematic productions integrated with sister subsidiary Cube Wellness Technologies' AI-enabled point-of-sale machines. CEO Patrick Bertagna emphasized the strategic fit of Collins' creative vision and relationships to build a next-generation content platform.

• ·Headquarters: Los Angeles, California
• ·Industry focus: Artificial Intelligence, IoT, Media & Content, Automated Retail
• ·Cube X Media content targets: digital advertising, vertical video, cinematic productions for AI-enabled retail and digital platforms
• ·Deployment targets for Cube Wellness: universities, institutional environments, workplaces, community locations

16-04-2026

Effective April 16, 2026, Aircastle Limited's Board saw the resignation of Takayuki Sakakida (Chairman since April 2024) and Takashi Tsunoda (Director since June 2024). Tomoaki Ogasawara was appointed as the new Chairman and director, and Satoshi Irie as a new director, both nominated by Marubeni Corporation pursuant to the Company's Bye-Laws; neither will receive compensation. These changes maintain board continuity with Marubeni representation.

• ·Takayuki Sakakida served as Director since March 2020 and was a member of the Investment, Audit, Risk & Governance, and Compensation Committees.
• ·Takashi Tsunoda served as Director since June 2024.
• ·Tomoaki Ogasawara: Joined Marubeni in 1996; Managing Director of Total Engine Asset Management (Singapore JV with ST Engineering) from 2024 to March 2026; previously General Manager of Marubeni’s Aircraft Leasing Business Department; graduate of Hitotsubashi University.
• ·Satoshi Irie: Joined Marubeni in 1999; currently General Manager of Asset Finance Department; General Manager of Finance, Leasing & Real Estate at Marubeni ASEAN Pte. Ltd. (2021-2025); board member of AND Global Pte. Ltd.; holds bachelor’s in economics from Hitotsubashi University.

16-04-2026

SecureTech Innovations, Inc. (OTCQB: SCTH) nominated Robert J. Williams, CPA, as an Independent Director and member of the Audit, Nomination, and Compensation Committees, completing its slate of three independent directors alongside Brian Zucker, CPA, and Robert V. Castro, CPA, CGMA. This supports the company's efforts to meet independent director requirements for a planned NASDAQ Capital Market listing, with appointments effective upon listing approval. Mr. Williams brings over 40 years of experience, including 20 years at Ernst & Young as Partner-in-Charge of Real Estate Tax Practice, U.S. Treasury advising, and U.S. Department of Justice consultations.

• ·Press release dated April 14, 2026; SEC filing on April 16, 2026.
• ·Mr. Williams authored a 1993 article on IRC Section 263A, a standard reference in real estate tax.
• ·Mr. Williams served as tax leader on forensic accounting for a major 1980s savings and loan investigation cited in Congressional testimony.

16-04-2026

TerrAscend Corp. (TSX: TSND; OTCQX: TSNDF) announced the appointment of Eric Jackson as Chief Financial Officer, effective April 27, 2026. Jackson brings over 20 years of finance and operational leadership from roles at American Signature, Inc. (EVP and CFO for over 8 years) and L Brands (14+ years in senior finance and operations roles). Ziad Ghanem, President and CEO, praised Jackson's expertise in efficiency, margins, and scaling operations.

• ·TerrAscend operates in Pennsylvania, New Jersey, Maryland, Ohio, California, and retail in Canada.
• ·Mr. Jackson holds a Bachelor of Science in Business from Miami University and a Master of Business Administration from The Ohio State University.
• ·Investor contacts: Ziad Ghanem (IR@terrascend.com, 689-345-4114); Valter Pinto (KCSA Strategic Communications, 212-896-1254).